Search Results - "Garrison LP"

Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting.

Authors: Bergenstal RM Garrison LP Miller LA et al.

Source: Current Medical Research & Opinion. 2011 Dec, Vol. 27 Issue 12, p2335-2342. 8p.

Regulatory benefit-risk assessment and comparative effectiveness research: strangers, bedfellows or strange bedfellows?

Authors: Garrison LP Garrison, Louis P

Source: PharmacoEconomics. 2010, Vol. 28 Issue 10, p855-865. 11p.

Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.

Authors: Towse A Garrison LP Jr Towse, Adrian et al.

Source: PharmacoEconomics. 2010, Vol. 28 Issue 2, p93-102. 10p.

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report-Part II.

Authors: Garrison LP Jr Mansley EC Abbott TA 3rd et al.

Source: Value in Health. Jan/Feb2010, Vol. 13 Issue 1, p8-13. 6p.

The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer.

Authors: Carlson JJ Garrison LP Ramsey SD et al.

Source: Value in Health. Jan/Feb2009, Vol. 12 Issue 1, p20-27. 8p.

Implications of Part D for mentally ill dual eligibles: a challenge for Medicare: Medicare's greatest challenge will be to regulate and monitor private prescription drug plans to assure quality and protect beneficiaries.

Authors: Morden NE Garrison LP Jr.

Source: Health Affairs. Mar/Apr2006, Vol. 25 Issue 2, p491-500. 10p.

URL: 20416877

Retrospective outcomes studies for orphan diseases: challenges and opportunities.

Authors: Sun P Garrison LP

Source: Current Medical Research & Opinion. Apr2012, Vol. 28 Issue 4, p665-667. 3p.

MSR34 A Pragmatic Guide to Assessing Real Option Value for Medical Technologies.

Authors: Li, M Garrison, LP Lee, W et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS524-S524. 1p.

EE462 Value-Based Pricing for Patent-Protected Medicines: Pricing Anomalies in the "Age of Cures" and Their Implications for Dynamic Efficiency.

Authors: Garrison, LP Jiao, B Dabbous, O

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS425-S425. 1p.

EE263 Impact of Treatment Duration on the Potential Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Early Symptomatic Alzheimer's Disease.

Authors: Boustani, M Garrison, LP Smolen, L et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS385-S385. 1p.

EE210 Value of Expanding First-Line Treatment Choices: New Metrics for Economic Evaluation.

Authors: Jiao, B Carlson, JJ Garrison, LP et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS374-S375. 2p.

PND23 - Projecting the Potential Cost Effectiveness of Ocrelizumab Versus Standard Care in Primary Progressive Multiple Sclerosis Patients Under Alternative Pricing Scenarios.

Authors: Suh, K Carlson, JJ Garrison, LP

Source: Value in Health. May2016, Vol. 19 Issue 3, pA62-A63. 1p.

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report-Part I.

Authors: Hay JW Smeeding J Carroll NV et al.

Source: Value in Health. Jan/Feb2010, Vol. 13 Issue 1, p3-7. 5p.

HSD7 Does Clinical Evidence of Heterogeneity Influence Treatment Selection? a Case Study of Abiraterone Acetate for Metastatic Castration-Sensitive Prostate Cancer.

Authors: Jiao, B Nyame, Y Carlson, JJ et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS481-S481. 1p.

EE436 Estimating the Potential Economic Impact of Tissue VS. Mechanical Surgical Replacement in Mainland China from a Societal Perspective.

Authors: Wu, E Rassloff, D Moore, M et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS420-S420. 1p.

EE112 A Population-Level Macroeconomic Model of the Potential Societal Impact of Using Tissue VS. Mechanical Surgical Aortic Valves in Mainland China.

Authors: Wang, B Rassloff, D Moore, M et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS356-S356. 1p.

PRM26 - Precision Heor: Using Big Data to Develop a Personalized Modeling Framework.

Authors: Chen, Y Wang, BC Furnback, W et al.

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA853-A853. 1p.

Beaked whale dive behavior and acoustic detection range off Louisiana using three-dimensional acoustic tracking.

Authors: Frouin-Mouy H Frasier KE Hildebrand JA et al.

Source: PloS one [PLoS One] 2026 Feb 04; Vol. 21 (2), pp. e0340398. Date of Electronic Publication: 2026 Feb 04 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States.

Authors: Gordan LN Bensimon AG Mu F et al.

Source: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 910-920. Date of Electronic Publication: 2025 Jun 14.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

Economic value of ribociclib in early breast cancer in the United States.

Authors: Brufsky A Tolaney SM Gadi VK et al.

Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2026 Aug; Vol. 32 (8), pp. 911-922.

Publication Type: Journal Article

Journal Info: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE